Rheumatoid Arthritis Trial, Recruiting (NCT05278520)

Rheumatoid Arthritis Trial, Recruiting NCT05278520 Sponsor: University of Turku Condition: Rheumatoid Arthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05278520 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rheumatoid Arthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Main study – Case group:

Adults who have osteoarthritis in the hip joint and are scheduled for a planned total hip replacement surgery

Main study – Control group:

Adults who do not have arthritis and are having an emergency total hip replacement surgery due to a trauma (such as a fracture)

Rheumatoid arthritis sub-study:

Adults who have rheumatoid arthritis in the hip joint and are scheduled for a planned total hip replacement surgery

Who may not be able to join:

People with a body mass index (BMI) of 35 or higher
People under 18 or over 74 years of age
People in the main study osteoarthritis group who also have diabetes, rheumatoid arthritis, or metabolic syndrome
People in the rheumatoid arthritis sub-study who also have diabetes or metabolic syndrome (having rheumatoid arthritis is not an exclusion for this sub-study)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lea Mikkola, PhD, Turku Bioscience, University of Turku

Phone: +358404143300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05278520

Sponsor: University of Turku

Phase: Not Applicable

Status: Recruiting

Condition: Rheumatoid Arthritis

Trial contact: +358404143300

More information: https://clinicaltrials.gov/study/NCT05278520

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Main study – Case group:

Adults who have osteoarthritis in the hip joint and are scheduled for a planned total hip replacement surgery

Main study – Control group:

Adults who do not have arthritis and are having an emergency total hip replacement surgery due to a trauma (such as a fracture)

Rheumatoid arthritis sub-study:

Adults who have rheumatoid arthritis in the hip joint and are scheduled for a planned total hip replacement surgery

Who may not be able to join:

People with a body mass index (BMI) of 35 or higher
People under 18 or over 74 years of age
People in the main study osteoarthritis group who also have diabetes, rheumatoid arthritis, or metabolic syndrome
People in the rheumatoid arthritis sub-study who also have diabetes or metabolic syndrome (having rheumatoid arthritis is not an exclusion for this sub-study)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Turku

Registry

ClinicalTrials.gov

Start date

11 January 2023

Est. completion

1 December 2028

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Characterization of cell populations in OA; Comparison of cell populations between OA cases and controls; Cellular landscape in OA; Key molecular pathways of OA; Comparison of disease mechanisms between RA and OA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov